{"success":true,"data":{"pressRelease":{"id":"128320","rtpr_id":"nGNX8q03cT","ticker":"INSP","exchange":"NYSE","all_tickers":["INSP"],"title":"Inspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference","author":"Globe Newswire","published_at":"2026-08-26T13:15:00.174Z","article_body":"MINNEAPOLIS, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc.\n(NYSE: INSP) (Inspire), a medical technology company focused on the\ndevelopment and commercialization of innovative, minimally invasive solutions\nfor patients with obstructive sleep apnea, announced today that its management\nteam will present at the Wells Fargo 21(st) Annual Healthcare Conference on\nWednesday, September 9, 2026.\n\nInspire is scheduled to present at 1:30 p.m. Eastern Time. The presentation\nwill be accessible via a live webcast here\n(https://www.globenewswire.com/Tracker?data=34j2EE6Sz2EEXSMInu2-TjY5mmxeTaZiEAGC-WRvCZ86cpV78JYrTsHy7Wodha5e9YlswoOA8bc9329r0rZNXAMIsFp-GobkYI_M749BM5JQJeJfyKAHGWfUo6A4DoxhbWRcaHvQxcgHMKUwL6gkpYnFf_-8wTyKsPOxtrdbUsNWSiigSAQHnNveTTtPL9WPhdmRzat35q3jutqGfZ3YSkjT25ppoLUU6ruvGF4JWZ4wPQUC3_N9_1pn5zjf9uQT_FVHzT9bplf2fTIAa07yiO4lrlModCkQaMgPWzOqXhVhh2sYBgG62dMj44F872AsR5X7XcEbV6NbIa0iv96sf2muaHmpyJ1B2js4ojWSQkepyUc-G5arMmYOeP1dxZlXei_PjPVPTU-nAB8YkWf9K2CvVThhiiavygTv3P9ZXIBi3zDJf-tcjRpFxMOMpbL90QLINljbuO7HAHdJuRwquwhRLCOSfzyK_NUC3nfSkt3CYn4vrQnWhk-FpzIs1RxIFQEHaPXR9Qy1umJC8QHfQg==).\n\nA webcast replay of the presentation will be available for two weeks following\nthe presentation in the Event Archive section of Inspire’s Investor website\nat https://investors.inspiresleep.com.\n\nAbout Inspire Medical Systems\nInspire is a medical technology company focused on the development and\ncommercialization of innovative, minimally invasive solutions for patients\nwith obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the\nfirst FDA, EU MDR, and PDMA-approved neurostimulation technology that provides\na safe and effective treatment for moderate to severe obstructive sleep apnea.\n\nFor additional information about Inspire, please visit www.inspiresleep.com.\n\nInvestor and Media Contact\nLouisa Smith\nPrincipal, Gilmartin Group\nIR@inspiresleep.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/194e83a5-3f7e-4805-88ce-da2e0ab594df)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX8q03cT","title":"Inspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference","author":"Globe Newswire","ticker":"INSP","created":"2026-08-26T13:15:00.174Z","tickers":["INSP"],"exchange":"NYSE","article_body":"MINNEAPOLIS, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc.\n(NYSE: INSP) (Inspire), a medical technology company focused on the\ndevelopment and commercialization of innovative, minimally invasive solutions\nfor patients with obstructive sleep apnea, announced today that its management\nteam will present at the Wells Fargo 21(st) Annual Healthcare Conference on\nWednesday, September 9, 2026.\n\nInspire is scheduled to present at 1:30 p.m. Eastern Time. The presentation\nwill be accessible via a live webcast here\n(https://www.globenewswire.com/Tracker?data=34j2EE6Sz2EEXSMInu2-TjY5mmxeTaZiEAGC-WRvCZ86cpV78JYrTsHy7Wodha5e9YlswoOA8bc9329r0rZNXAMIsFp-GobkYI_M749BM5JQJeJfyKAHGWfUo6A4DoxhbWRcaHvQxcgHMKUwL6gkpYnFf_-8wTyKsPOxtrdbUsNWSiigSAQHnNveTTtPL9WPhdmRzat35q3jutqGfZ3YSkjT25ppoLUU6ruvGF4JWZ4wPQUC3_N9_1pn5zjf9uQT_FVHzT9bplf2fTIAa07yiO4lrlModCkQaMgPWzOqXhVhh2sYBgG62dMj44F872AsR5X7XcEbV6NbIa0iv96sf2muaHmpyJ1B2js4ojWSQkepyUc-G5arMmYOeP1dxZlXei_PjPVPTU-nAB8YkWf9K2CvVThhiiavygTv3P9ZXIBi3zDJf-tcjRpFxMOMpbL90QLINljbuO7HAHdJuRwquwhRLCOSfzyK_NUC3nfSkt3CYn4vrQnWhk-FpzIs1RxIFQEHaPXR9Qy1umJC8QHfQg==).\n\nA webcast replay of the presentation will be available for two weeks following\nthe presentation in the Event Archive section of Inspire’s Investor website\nat https://investors.inspiresleep.com.\n\nAbout Inspire Medical Systems\nInspire is a medical technology company focused on the development and\ncommercialization of innovative, minimally invasive solutions for patients\nwith obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the\nfirst FDA, EU MDR, and PDMA-approved neurostimulation technology that provides\na safe and effective treatment for moderate to severe obstructive sleep apnea.\n\nFor additional information about Inspire, please visit www.inspiresleep.com.\n\nInvestor and Media Contact\nLouisa Smith\nPrincipal, Gilmartin Group\nIR@inspiresleep.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/194e83a5-3f7e-4805-88ce-da2e0ab594df)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-08-26T13:15:00.210943762Z","server_sent_at_ms":1787750100210},"received_at":"2026-08-26T13:15:00.261Z","source_url":"https://www.globenewswire.com/news-release/2026/08/26/3351428/0/en/inspire-medical-systems-inc-to-present-at-the-wells-fargo-21st-annual-healthcare-conference.html"},"analysis":{"id":"117234","press_release_id":"128320","analysis_json":{"industry":{"label":"Health Care Equipment & Supplies","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"Inspire Medical Systems announced that its management team will present at the Wells Fargo 21st Annual Healthcare Conference on September 9, 2026.\n\nThe presentation is scheduled for 1:30 p.m. Eastern Time and will be accessible via a live webcast.\n\nA replay of the session will be available on the company's investor website for two weeks following the event.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine conference attendance disclosure; no material news content."},"keyFigures":null,"quotedText":"","namedEntities":{"people":[{"name":"Louisa Smith","role":"Investor and Media Contact"}],"products":["Inspire therapy"],"companies":[{"name":"Inspire Medical Systems, Inc.","ticker":"INSP"},{"name":"Wells Fargo","relationship":"conference organizer"},{"name":"Gilmartin Group","relationship":"investor relations firm"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Routine announcement of management participation at an investor conference. No financial results, strategic updates, or material business developments were disclosed."},"tickerRelevance":{"others":[],"primary":"INSP"},"globalImportance":5,"audienceRelevance":15,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid-cap","eventGravity":"routine_conference_announcement"}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Inspire Medical Systems announced that its management team will present at the Wells Fargo 21st Annual Healthcare Conference on September 9, 2026.\n\nThe presentation is scheduled for 1:30 p.m. Eastern Time and will be accessible via a live webcast.\n\nA replay of the session will be available on the company's investor website for two weeks following the event.","key_figures":null,"named_entities":{"people":[{"name":"Louisa Smith","role":"Investor and Media Contact"}],"products":["Inspire therapy"],"companies":[{"name":"Inspire Medical Systems, Inc.","ticker":"INSP"},{"name":"Wells Fargo","relationship":"conference organizer"},{"name":"Gilmartin Group","relationship":"investor relations firm"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-08-26T14:54:33.418Z","global_importance":5,"audience_relevance":15,"importance_components":{"tickerTier":"mid-cap","eventGravity":"routine_conference_announcement"}},"durationMs":166614,"modelName":"glm-4.7"}}